They assured investors they had everything under control when the opposite was true
When a company tells its investors that a major acquisition is flourishing while operational cracks quietly widen beneath the surface, it raises one of the oldest questions in commerce: what do those who hold power owe those who place their trust in them? Neogen Corporation now faces that reckoning, as shareholders who bought stock between early 2023 and mid-2025 allege the company painted a rosier picture of its integration than reality warranted. A class action lawsuit, shepherded by Rosen Law Firm, invites those investors to seek accountability before a September 16, 2025 deadline — a case that may ultimately shape how corporations are expected to speak truthfully during the turbulent seasons of growth.
- Neogen's leadership repeatedly assured investors the acquisition integration was succeeding, using language like 'off to a great start' and 'solid core growth' — even as serious operational problems were allegedly taking root.
- When cracks became impossible to ignore, executives told shareholders they had 'our arms around the key issues,' a reassurance the lawsuit contends was as misleading as the optimism that preceded it.
- Investors who purchased Neogen stock during the affected window say they suffered real financial harm when the true state of the integration finally surfaced publicly.
- Rosen Law Firm is now racing against a September 16, 2025 deadline to recruit lead plaintiffs, offering contingency-based representation so shareholders can pursue claims without paying upfront legal costs.
- No class has been certified yet, meaning investors must decide now whether to take an active role, wait as absent members, or secure their own independent counsel.
A New York law firm is calling on Neogen Corporation shareholders to join a class action lawsuit before a September 16, 2025 deadline, alleging the company misled investors about the health of a major acquisition integration between early 2023 and mid-2025.
At the heart of the case is a pattern of reassurance the lawsuit says did not match reality. Neogen's leadership described the integration as 'off to a great start,' cited strong profitability, and when problems emerged, told investors they had the situation in hand and were committed to resolving it. The lawsuit contends that when the true picture finally became public, shareholders paid the price in damaged investment value.
Rosen Law Firm, which is handling the litigation on a contingency basis — collecting fees only if the case succeeds — is urging affected investors to come forward. The firm points to a substantial track record in securities class actions, including a top ranking for settlements in 2017 and over $438 million recovered for investors in 2019 alone.
Investors have options: they can seek to become lead plaintiffs and help direct the litigation, remain as absent class members, or hire independent counsel. Importantly, participating in any eventual recovery does not require serving as lead plaintiff. But for those who want an active role, the September 16 deadline is the threshold that matters.
A law firm in New York is calling on investors who bought Neogen Corporation stock between early 2023 and mid-2025 to join a class action lawsuit alleging the company misled them about how smoothly a major acquisition was being integrated. The deadline to become a lead plaintiff—a representative shareholder directing the litigation—is September 16, 2025.
The case centers on what the lawsuit describes as false reassurances. At the start of the period in question, Neogen's leadership told investors the integration was "off to a great start" and that the company had achieved "solid core growth" with profitability "well ahead of where the company was prior to the acquisition." When operational problems surfaced, executives downplayed them, telling shareholders they had "our arms around the key issues" and were "fully committed to resolving them in the near future." The lawsuit alleges this picture did not match reality. When the true state of the integration eventually became public, investors say they suffered financial damage.
Rosen Law Firm, which is handling the case, is emphasizing that shareholders who purchased stock during this window may be entitled to compensation at no upfront cost. The firm works on a contingency basis, meaning it collects fees only if the case succeeds. Investors interested in joining can submit information through the firm's website, call attorney Phillip Kim toll-free, or email the firm directly.
The firm is also making a broader pitch about why investors should choose experienced counsel. Rosen notes that many law firms issuing notices in class actions do not actually litigate the cases themselves but instead act as middlemen, referring clients to other firms that handle the actual work. The firm points to its own track record: it was ranked number one by ISS Securities Class Action Services for the number of settlements in 2017 and has remained in the top four every year since 2013. In 2019 alone, the firm recovered over $438 million for investors. Its founding partner, Laurence Rosen, was named a Titan of the Plaintiffs' Bar by Law360 in 2020.
It is important to note that no class has been certified yet. Until that happens, investors are not automatically represented by counsel unless they hire one themselves. Shareholders can choose their own lawyer, remain as absent class members and do nothing for now, or become lead plaintiffs. The ability to share in any eventual recovery does not depend on serving as lead plaintiff—that role is simply a way to help direct the case. The firm is urging investors to act before the September 16 deadline if they want to pursue a leadership position in the litigation.
Citas Notables
Integration was 'off to a great start' with profitability 'well ahead of where the company was prior to the acquisition'— Neogen leadership, according to the lawsuit
We have our arms around the key issues and are fully committed to resolving them in the near future— Neogen executives, regarding integration inefficiencies
La Conversación del Hearth Otra perspectiva de la historia
What exactly did Neogen say that was false?
They told investors the acquisition integration was going smoothly—"off to a great start," they said—and that profitability was ahead of expectations. But the lawsuit claims the opposite was happening behind the scenes. There were serious operational problems they downplayed as minor "inefficiencies."
So they knew things were going badly and hid it?
That's what the lawsuit alleges. They acknowledged some inefficiencies existed but assured investors they had everything under control and would fix it soon. When the real situation came out, the stock price presumably fell, and shareholders lost money.
Why does it matter whether someone becomes a lead plaintiff versus just joining the class?
A lead plaintiff essentially represents all the other shareholders in directing the case—making decisions about strategy, settlement negotiations, that kind of thing. Most people don't need to do that. They can just be part of the class and share in any recovery without the extra responsibility.
And there's no cost to join?
Correct. The law firm works on contingency, so they only get paid if they win or settle. Investors don't pay anything upfront.
What's the deadline really about?
September 16 is when the court stops accepting new lead plaintiff applications. After that, the case moves forward with whoever is already in place. If you want a say in how the litigation unfolds, you need to move by then.
Has the class been certified yet?
No. That's still to come. Until it is, technically no one is represented unless they've hired their own lawyer. But once it's certified, everyone who bought stock during that window will be part of it automatically, whether they did anything or not.